Sunday, 27 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Biocytogen Completes DeepSeek Localization, Integrates with “Thousand Mice, Ten Thousand Antibodies” Plan
March 1, 2025
Company
BeiGene’s Q4 and 2024 Financials Highlight Significant Growth and Product Success
February 28, 2025
Company
Zai Lab Q2 and Full-Year 2024 Report Shows Sales Growth and Loss Reduction
February 28, 2025
Company
Viatris Q4 and Full-Year Results Show Greater China Growth
February 28, 2025
Company
Deals
SciClone Pharmaceuticals Licenses Eisai’s Tasurgratinib for China
February 28, 2025
Company
Drug
Fosun Pharmaceutical’s XS-03 Gets NMPA Green Light for CRC Study
April 2, 2025
Company
Deals
Sino Biopharmaceutical and Sciwind Biosciences Partner on CPX102 Development
February 28, 2025
Company
Drug
Bayer’s BlueRock Therapeutics Gets Fast Track for OpCT-001 Therapy
February 28, 2025
Company
Drug
Chipscreen Biosciences’ CS12088 Gets NMPA Clearance for Hepatitis B Study
February 28, 2025
Company
Drug
Hengrui Pharmaceuticals Gets NMPA Green Light for SHR-A2009 Study
February 28, 2025
Company
GE Healthcare’s China CEO Yihao Zhang to Retire, Will Song Named Successor
February 28, 2025
Company
Medical Device
Zhongsheng Pharmaceutical’s RAY1225 Gets Green Light for Phase III Study
February 28, 2025
1
2
…
438
439
440
441
442
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?